Core Viewpoint - Acadia Healthcare Company, Inc. will participate in multiple investor conferences in March 2026, showcasing its position as a leading provider of behavioral healthcare services in the U.S. [1] Group 1: Investor Conferences - The company will participate in the Raymond James & Associates' 47th Annual Institutional Investors Conference from March 1-4, 2026, with a presentation on March 2 at 11:35 a.m. ET [1] - Acadia will also attend the Leerink Partners 2026 Global Healthcare Conference from March 9-12, 2026, presenting on March 9 at 3:40 p.m. ET [1] - Additionally, the company will be part of the Barclays 28th Annual Global Healthcare Conference from March 10-12, 2026, with a presentation scheduled for March 10 at 12:00 p.m. ET [1] Group 2: Company Overview - As of September 30, 2025, Acadia operates 278 behavioral healthcare facilities with approximately 12,500 beds across 40 states and Puerto Rico [1] - The company employs around 25,500 staff and serves over 82,000 patients daily, making it the largest stand-alone behavioral healthcare company in the U.S. [1] - Acadia provides a range of behavioral healthcare services in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics [1]

Core Viewpoint - INOVIO Pharmaceuticals is preparing for two major investor conferences in December to showcase its strategic initiatives and engage with investors [1][6] Group 1: Upcoming Conferences - The first conference is the Piper Sandler 37th Annual Healthcare Conference on December 2 in New York, where INOVIO will participate in a fireside chat available via live webcast [2] - The second event is the Oppenheimer Movers in Rare Disease Summit on December 11, where INOVIO will join a panel discussing key near-term catalysts [3] Group 2: Stock Performance - INOVIO's stock price was $1.95 at the time of the Piper Sandler announcement but has decreased to $1.79, reflecting a 5.29% decline [2][3] - The stock has fluctuated between $1.78 and $1.90 on the day of reporting, with a market capitalization of approximately $95.93 million [4] - Over the past year, INOVIO's stock reached a high of $4.61 and a low of $1.30, with a trading volume of 1,073,702 shares on NASDAQ [5]

Core Insights - Journey Medical Corporation is a commercial-stage pharmaceutical company focused on FDA-approved prescription products for dermatological conditions [1][2] - The company will participate in two investor conferences in October 2025, indicating active engagement with the investment community [1][2] Event Details - The 4th Annual ROTH Healthcare Opportunities Conference will take place on October 9, 2025, in New York City, featuring 1x1 meetings [2] - The ThinkEquity Conference is scheduled for October 30, 2025, also in New York City, and will include presentations and 1x1 meetings [2] Company Overview - Journey Medical markets eight branded FDA-approved prescription drugs aimed at treating common skin conditions [2] - The company is based in Scottsdale, Arizona, and was founded by Fortress Biotech, Inc. [2] - Journey Medical's stock is registered under the Securities Exchange Act of 1934 and files periodic reports with the SEC [2]

Company Overview - TEN Holdings, Inc. operates through its subsidiary, Ten Events, Inc., providing event planning, production, and broadcasting services, primarily focusing on virtual, hybrid, and physical events [4] - The company is headquartered in Pennsylvania and utilizes its proprietary Xyvid Pro Platform to support its services [4] Upcoming Investor Events - TEN Holdings will participate in several key investor-focused events in 2025, including the MicroCap Rodeo, LD Micro Main Event, and Spartan Capital Investor Conference [3][6] - These events are seen as critical for enhancing brand awareness and building relationships within the U.S. investment community [3] Event Details - **MicroCap Rodeo Fall Conference**: Scheduled for September 25, 2025, in New York, featuring approximately 15 microcap companies and opportunities for investors to discover unique stock ideas [6] - **LD Micro Main Event XIX**: Taking place from October 19-21, 2025, in San Diego, this event is renowned for small- and micro-cap companies, offering keynote speeches, presentations, and networking opportunities [6] - **Spartan Capital Investor Conference 2025**: Set for November 3, 2025, in New York City, this conference will include over 50 public and private companies, facilitating interactions between growth-stage companies and investors [6]

Group 1 - Data I/O Corporation will participate in the Singular Research Summer Solstice Conference on June 18, 2025, with a presentation scheduled for 3:00 PM ET in New York [1] - The company will also present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference on June 24, 2025, at 11:30 AM ET, followed by one-on-one meetings on June 25 [2] - Data I/O has been providing innovative solutions since 1972, focusing on electronic products for various sectors including automotive, IoT, medical, and consumer electronics [3] Group 2 - The company's data provisioning solutions allow OEMs to manage device intellectual property from inception to deployment, ensuring reliable and cost-effective product development [3] - Data I/O's offerings are supported by a portfolio of patents and a global network of support professionals, enhancing customer success [3]